Biomerica shareholders approve reverse stock split authorization and 2024 Stock Incentive Plan

BIOMERICA INC

All five director nominees elected with overwhelming support; broker non-votes 5.5M.
Say-on-pay passed with 4.6M for vs 275K against; auditor Haskell & White ratified.
2024 Stock Incentive Plan approved (4.2M for, 730K against); 5.5M broker non-votes.
Reverse stock split authorization approved 9.8M for, 558K against; no broker non-votes.
Authorized share increase passed 9.6M for; adjournment proposal also approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.